Download PDF
Semin intervent Radiol 2010; 27(1): 099-104
DOI: 10.1055/s-0030-1247891
HOW I DO IT

© Thieme Medical Publishers

Embolization Agents—Which One Should Be Used When? Part 2: Small-Vessel Embolization

Michael Lubarsky1 , Charles Ray2 , Brian Funaki1
  • 1Department of Radiology, Emory University School of Medicine, Chicago, Illinois
  • 2Section of Vascular and Interventional Radiology, University of Chicago Medical Center, Chicago, Illinois
Further Information

Publication History

Publication Date:
13 March 2010 (online)

Also available at
    Permissions and Reprints

In Part 1 of this two-part article, we discussed commonly used large-vessel embolic agents and clinical scenarios in which the agents might be used. We also discussed how to choose between the multitude of embolic agents that are currently commercially available. In this article, we will focus on embolic agents used to occlude small vessels and when to choose which agent.

It is vital to recognize one important characteristic of all embolic agents: regardless of composition, the smaller the agent, the greater the likelihood of organ ischemia. Most organs have some duplication of vascular supply; this collateralization is vital to organ survival following a proximal vascular event. If very small embolic agents are used, the effective level of the embolization is distal to where the collateral vessels join the main feeding artery, thereby effectively occluding inflow from both the primary and collateral circulations. Therefore, for most organ systems, small agents cause much greater ischemia than larger agents.

SUGGESTED READINGS

  • 1 Loffroy R, Guiu B, Cercueil J P, Krausé D. Endovascular therapeutic embolisation: an overview of occluding agents and their effects on embolised tissues.  Curr Vasc Pharmacol. 2009;  7 250-263
    CrossrefPubMedGoogle Scholar
  • 2 Abada H T, Golzarian J. Gelatine sponge particles: handling characteristics for endovascular use.  Tech Vasc Interv Radiol. 2007;  10 257-260
    CrossrefPubMedGoogle Scholar
  • 3 Laurent A. Microspheres and nonspherical particles for embolization.  Tech Vasc Interv Radiol. 2007;  10 248-256
    CrossrefPubMedGoogle Scholar
  • 4 Howington J U, Kerber C W, Hopkins L N. Liquid embolic agents in the treatment of intracranial arteriovenous malformations.  Neurosurg Clin N Am. 2005;  16 355-363, ix–x
    CrossrefPubMedGoogle Scholar

Brian FunakiM.D. 

Section of Vascular and Interventional Radiology, University of Chicago Medical Center

5840 S. Maryland Avenue, MC 2026, Chicago, IL 60637

      >